10/30/2022 0 Comments Retina consultants of houston![]() ![]() 10Retina Consultants of Texas Retina Consultants of America Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, USA. Currently Retina Consultants Of Houstons 2 physicians cover 1 specialty areas of medicine. 9Wills Eye Hospital, Philadelphia, PA, USA. Retina Consultants Of Houston is a Practice with 1 Location. 8Retina Vitreous Associates Medical Group, Los Angeles, CA, USA. 7Division of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel. 6New England Retina Consultants, Springfield, MA, USA. Schmidt School of Medicine, Boca Raton, FL, USA. Eye Institute, Deerfield Beach, FL, USA Florida Atlantic University, Charles E. 3Eye Clinic, Department of Biomedical and Clinical Sciences "Luigi Sacco," University of Milan, Milan, Italy 4Université de Paris, Ophthalmology Department, AP-HP, Hôpital Lariboisière, Paris, France 5Rand. 2West Texas Retina Consultants, Abilene, TX, USA. #Retina consultants of houston updateWhile the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so except as required by law.Įfficacy of Intravitreal Avacincaptad Pegol in Geographic AtrophyĪrshad M Khanani, MD, MA 1 Sunil S Patel, MD, PhD 2 Giovanni Staurenghi, MD 3 Ramin Tadayoni, MD, PhD 4 Carl J Danzig, MD 5 David R Lally, MD 6 Anat Loewenstein, MD 7 David S Boyer, MD 8 Carl D Regillo, MD 9 Tien P Wong, MD 10 Glenn J Jaffe, MD 11 Justin Tang, PhD 12 Liansheng Zhu, PhD 12 Hersh Patel, OD 12 Julie Clark, MD 12ġSierra Eye Associates, Reno, NV, USA University of Nevada, Reno School of Medicine, Reno, NV, USA. The Company anticipates that subsequent events and developments may cause its views to change. Such risks and uncertainties include, among others, the progress and results of clinical trials and other research and development programs, developments from the scientific and medical community and from the Company's competitors, and other factors discussed in the "Risk Factors" section contained in the quarterly and annual reports that the Company files with the Securities and Exchange Commission.Īny forward-looking statements represent the Company's views only as of the date of this presentation. Such forward-looking statements involve substantial risks and uncertainties that could cause the Company's research and development programs, future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. #Retina consultants of houston trialIn this presentation, the Company's forward-looking statements include statements about the significance and implications of the Company's GATHER2 clinical trial evaluating avacincaptad pegol (ACP or Zimura) for the treatment of geographic atrophy, and the potential utility of ACP. Forward-looking statements include statements about the strategy, operations and future expectations and plans and prospects for the Company, and any other statements containing the words "anticipate," "believe," "estimate," "expect," "intend", "goal," "may", "might," "plan," "predict," "project," "seek," "target," "potential," "will," "would," "could," "should," "continue," and similar expressions. Shawn has strength in the retina field having published in several major retina and ophthalmology publications including co-authoring in the American Journal of Ophthalmology.Any statements in this presentation about IVERIC bio (the Company)'s future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. He has served on pharmaceutical advisory boards including Genentech & Regeneron and has presented at multiple national conferences including ASRS and at the NextGen User Group Meeting. At Retina Consultants of Houston, he made an impact by continuously finding efficiencies and identifying opportunities for system growth and market positions while showcasing skill in fiscal and operational management. He excels in communicating the vision and motivating team members to bring out the best in his team and develop their skillsets professionally. Shawn will utilize his vast understanding of the retina field and experience to facilitate and integrate best practices as new groups join the RCA family. Shawn takes the helm as Vice President of Operations and will draw on his experience at Retina Consultants of Houston as he continues to lead as the COO and Practice Administrator. He has navigated physician practice management, strategic planning and has extensive consulting experience having spent time at Ernst & Young. Shawn comes to RCA with a long history in healthcare. Shawn is a graduate of the University of Texas at Austin and holds a M.H.A. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |